Maximizing the Oral Bioavailability of Poorly Water-Soluble Drugs Using Novel Oil-Like Materials in Lipid-Based Formulations

被引:8
|
作者
Abbasi, Saed [1 ]
Higashino, Haruki [2 ]
Sato, Yusuke [3 ]
Minami, Keiko [2 ]
Kataoka, Makoto [2 ]
Yamashita, Shinji [2 ]
Harashima, Hideyoshi [3 ]
机构
[1] Kawasaki Inst Ind Promot, Innovat Ctr NanoMed, Kawasaki, Kanagawa 2100821, Japan
[2] Setsunan Univ, Fac Pharmaceut Sci, Osaka 5730101, Japan
[3] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan
基金
日本学术振兴会;
关键词
water insoluble drugs; pi-pi stacking; oral delivery; drug absorption; pharmaceutical solubilizer; IN-VIVO EVALUATION; DELIVERY SYSTEM; PRECIPITATION INHIBITORS; VITRO; ABSORPTION; INTESTINE; DIGESTION; LIPOLYSIS; SMEDDS;
D O I
10.1021/acs.molpharmaceut.1c00197
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lipid-based formulations, such as self-microemulsifying drug-delivery systems (SMEDDSs), are promising tools for the oral delivery of poorly water-soluble drugs. However, failure to maintain adequate aqueous solubility after coming into contact with gastrointestinal fluids is a major drawback. In this study, we examined the use of a novel cinnamic acid-derived oil-like material (CAOM) that binds drugs with a high affinity through pi-pi stacking and hydrophobic interactions, as an oil core in a SMEDDS for the oral delivery of fenofibrate in rats. The use of the CAOM in the SMEDDS resulted in an unprecedented enhancement in fenofibrate bioavailability, which exceeded the bioavailability values obtained using SMEDDSs based on corn oil, a conventional triglyceride oil, or Labrasol, an enhancer of intestinal permeation. Further characterization revealed that the CAOM SMEDDS does not alter the intestinal permeability and has no inhibitory activity on Pglycoprotein-mediated drug efflux. The results reported herein demonstrate the strong potential of CAOM formulations as new solubilizers for the efficient and safe oral delivery of drugs that have limited water solubility.
引用
收藏
页码:3281 / 3289
页数:9
相关论文
共 50 条
  • [21] An Intestinal "Transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs
    Chuang, Er-Yuan
    Lin, Kun-Ju
    Huang, Tring-Yo
    Chen, Hsin-Lung
    Miao, Yang-Bao
    Lin, Po-Yen
    Chen, Chiung-Tong
    Juang, Jyuhn-Huarng
    Sung, Hsing-Wen
    ACS NANO, 2018, 12 (07) : 6389 - 6397
  • [22] The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations
    Khan, Jamal
    Rades, Thomas
    Boyd, Ben
    PHARMACEUTICAL RESEARCH, 2016, 33 (03) : 548 - 562
  • [23] Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam
    Prabhu, S
    Ortega, M
    Ma, C
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 301 (1-2) : 209 - 216
  • [24] Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs
    Iwanaga, K
    Kushibiki, T
    Miyazaki, M
    Kakemi, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (03) : 508 - 512
  • [25] Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer
    Sugimoto, M
    Okagaki, T
    Narisawa, S
    Koida, Y
    Nakajima, K
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 160 (01) : 11 - 19
  • [26] Lipid-Based Drug Delivery System (LBDDS): An Emerging Paradigm to Enhance Oral Bioavailability of Poorly Soluble Drugs
    Roohi Kesharwani
    Pankaj Jaiswal
    Dilip Kumar Patel
    Pankaj Kumar Yadav
    Biomedical Materials & Devices, 2023, 1 (2): : 648 - 663
  • [27] Lipid-based systems for the enhanced delivery of poorly water soluble drugs
    Porter, Christopher J. H.
    Wasan, Kishor M.
    ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (06) : 615 - 616
  • [28] Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs
    Carriere, Frederic
    BIOCHIMIE, 2016, 125 : 297 - 305
  • [29] 'Stealth' lipid-based formulations: Poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug
    Feeney, Orlagh M.
    Williams, Hywel D.
    Pouton, Colin W.
    Porter, Christopher J. H.
    JOURNAL OF CONTROLLED RELEASE, 2014, 192 : 219 - 227
  • [30] 'Stealth' lipid-based formulations: Poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug
    Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville
    VIC
    3052, Australia
    不详
    NJ
    07960, United States
    J. Control. Release, (219-227):